JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141192

IQDMA, Cell-permeable STAT5 inhibitor

Be the first to review this product! Submit a review

|

(4 Publications)

MW 304.39 g/mol, Purity >98%. Cell-permeable STAT5 inhibitor (IC50 = 8 μM). Indoloquinoline derivative. Antineoplastic agent with broad spectrum antitumor activity seen in vitro. Induces cell-cycle arrest at the G2/M phase.
1 Images
Chemical Structure - IQDMA, Cell-permeable STAT5 inhibitor (AB141192)
  • Chemical Structure

Lab

Chemical Structure - IQDMA, Cell-permeable STAT5 inhibitor (AB141192)

2D chemical structure image of ab141192, IQDMA, Cell-permeable STAT5 inhibitor

Key facts

CAS number

401463-02-3

Purity

>98%

Form

Solid

form

Molecular weight

304.39 g/mol

Molecular formula

C<sub>1</sub><sub>9</sub>H<sub>2</sub><sub>0</sub>N<sub>4</sub>

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 100 mM

Biological description

Cell-permeable STAT5 inhibitor (IC50 = 8 μM). Indoloquinoline derivative. Antineoplastic agent with broad spectrum antitumor activity seen in vitro. Induces cell-cycle arrest at the G2/M phase.

Canonical smiles

CN(C)CCNC2NC1CCCCC1C3NC4CCCCC4C23

InChi

InChI=1S/C19H20N4/c1-23(2)12-11-20-19-17-13-7-3-5-9-15(13)21-18(17)14-8-4-6-10-16(14)22-19/h3-10,21H,11-12H2,1-2H3,(H,20,22)

InChiKey

UROLFQZUYMCOHV-UHFFFAOYSA-N

IUPAC Name

N2-11H-Indolo[3,2-c]quinolin-6-yl-N1,N1-dimethyl-1,2-ethanediamine

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Signal transduction and targeted therapy 9:352 PubMed39690159

2024

Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity.

Applications

Unspecified application

Species

Unspecified reactive species

Xu Jiang,Jiaqi Wang,Liangyu Lin,Liming Du,Yayun Ding,Fanjun Zheng,Hongzhen Xie,Yu Wang,Mingyuan Hu,Benming Liu,Muhan Xu,Jingjie Zhai,Xuefeng Wang,Jiayin Ye,Wei Cao,Chao Feng,Jingyi Feng,Zongliu Hou,Mingyao Meng,Ju Qiu,Qing Li,Yufang Shi,Ying Wang

American journal of cancer research 12:1129-1142 PubMed35411230

2022

Stat5b inhibition blocks proliferation and tumorigenicity of glioblastoma stem cells derived from a murine brain cancer model.

Applications

Unspecified application

Species

Unspecified reactive species

Chiami Moyama,Mitsugu Fujita,Shota Ando,Keiko Taniguchi,Hiromi Ii,Seisuke Tanigawa,Naoya Hashimoto,Susumu Nakata

Cancer research 80:1102-1117 PubMed31911557

2020

The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Eman Sami,Bibbin T Paul,James A Koziol,Wael M ElShamy

The Journal of steroid biochemistry and molecular biology 185:137-141 PubMed30125658

2018

Angiotensin 1-7 suppresses angiotensin II mediated aldosterone production via JAK/STAT signaling inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Kiyotaka Itcho,Kenji Oki,Kazuhiro Kobuke,Haruya Ohno,Masayasu Yoneda,Noboru Hattori
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com